This drug firm could hold the key to ameliorating an intractable neurological disease. Read More

Whether you’re a novice or veteran investor, it’s worth reviewing the stock market basics now and then. Here are three that will keep you on course. Read More

Despite this week’s disappointment the leading networker remains a solid recovery play. Read More

It’s time to reconsider how your cash and “safe funds” are invested. There’s at least one new option that pays more than a competitive yield and also delivers up to three times your money to cover any long-term care expenses you incur. Read More

The motorcycle maker, which is celebrating its 110th anniversary this year, continues to ride along with a rebounding economy. Read More

You can hold some of the country’s most successful companies with this Canadian ETF—and it’s just as easy as buying a U.S. stock. Read More

Estate planning no longer is primarily about taxes. Yet, you need a complete, up-to-date estate plan more than ever regardless of the value of your estate. Read More

The company’s second-biggest market is showing early signs of a U-turn, while more of its pickups roll out of North American dealerships. Read More

Despite this week’s profit warning, the future’s bright thanks to Chrysler and momentum in emerging markets. Read More

Leading producer Uralkali’s decision to pull out of a key marketing body has sparked a broad selloff of fertilizer stocks. Here’s why. Read More